Actigraphy Device Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Actigraphy Device Market size was more than USD 4.2 billion in 2026 and is set to grow at a 24.8% CAGR between 2027 and 2036, surpassing USD 38.49 billion by 2036. The industry revenue for 2027 is calculated at USD 5.08 billion.
Get more details on this report
Request Free Sample ReportActigraphy Device Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 37.91% share due to established sleep and behavioral health monitoring, widespread wearable diagnostic use, and strong integration into clinical research and long-term patient tracking.
- Asia Pacific growth is driven by rapid adoption of wearable health technologies, expanding digital health access, rising sleep disorder awareness, and use of non-invasive remote monitoring devices, at 27.83% CAGR.
Segment Momentum
- Healthcare providers lead the market because they prescribe, interpret, and integrate actigraphy data into clinical assessment, supporting established workflows for sleep evaluation and activity monitoring.
- Chronic disease management is the fastest-growing application as continuous monitoring of daily activity and sleep patterns increasingly supports long-term patient management and remote care decisions.
Market Expansion Drivers
- Rising prevalence of sleep disorders increasing demand for continuous sleep monitoring devices.
- Growing aging population accelerating adoption of non-invasive sleep assessment technologies.
- Expanding awareness of sleep health supporting personalized digital health monitoring adoption.
Leading Market Participants
- Leading companies in the actigraphy device market include Koninklijke Philips N.V. (Netherlands), ActiGraph, LLC (United States), Empatica Inc. (United States), CamNtech Ltd. (United Kingdom), Fibion Inc. (Finland), ActivInsights Ltd. (United Kingdom), neurocare group AG (Germany), Garmin Ltd. (Switzerland), Fitbit LLC (United States), Withings S.A. (France).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 4.2 billion
- 2027 Estimated Market Size: USD 5.08 billion.
- Projected Market Size: USD 38.49 billion by 2036
- Growth Forecast: 24.8% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Sleep Disorders (Application) | Healthcare Providers (End Use)
- Emerging Opportunity Segment: Chronic Disease Management (Application) | Homecare Settings (End Use)
Market Growth Drivers and Industry Trends
Rising prevalence of sleep disorders increasing demand for continuous sleep monitoring devices
The increasing prevalence of sleep disorders is creating a stronger need for accessible and continuous monitoring solutions, which will drive the actigraphy device market growth. Actigraphy devices enable prolonged observation of sleep-wake patterns through non-invasive monitoring, helping healthcare professionals and individuals identify irregular sleep behaviors and assess changes over time. Their ability to support monitoring outside clinical settings also makes them useful for repeated assessments, sleep management, and longitudinal observation, particularly where conventional sleep evaluation methods may be less convenient.
Growing aging population accelerating adoption of non-invasive sleep assessment technologies
As the global aging population expands, the need for convenient approaches to monitor age-related changes in sleep patterns is increasing, supporting the actigraphy device market. Older adults commonly require closer observation of sleep quality and daily activity rhythms, creating demand for technologies that can collect information without invasive procedures or prolonged clinical intervention. Actigraphy-based monitoring can facilitate routine assessment in home and care settings while providing continuous behavioral and sleep-related information that can assist healthcare professionals in evaluating changing sleep patterns.
Expanding awareness of sleep health supporting personalized digital health monitoring adoption
Greater awareness of sleep health is encouraging individuals to take a more proactive approach to understanding and managing their sleep patterns, thereby boosting the actigraphy device market demand. Consumers and healthcare providers are increasingly interested in digital monitoring technologies that provide individualized insights into activity and sleep cycles and can support ongoing wellness management. The availability of wearable and connected monitoring approaches also enables sleep-related information to be incorporated into personalized health routines, encouraging broader use of non-invasive digital assessment technologies.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of sleep disorders increasing demand for continuous sleep monitoring devices | 2.00% | Moderate | North America, Europe | High | Near Term |
| Growing aging population accelerating adoption of non-invasive sleep assessment technologies | 1.80% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding awareness of sleep health supporting personalized digital health monitoring adoption | 1.50% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the actigraphy device market, North America held the largest share in 2026, accounting for 37.91% share, supported by advanced healthcare infrastructure, strong adoption of digital health technologies, and growing use of objective monitoring tools in sleep and circadian rhythm assessment. The region benefits from established clinical research capabilities and increasing awareness of sleep-related disorders, encouraging healthcare providers and researchers to incorporate wearable actigraphy devices into diagnostic and monitoring workflows. Rising demand for remote patient monitoring and convenient, non-invasive assessment solutions is also strengthening adoption, while technological improvements in wearable sensors, data analytics, and connectivity are broadening the practical applications of actigraphy across healthcare and research settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth, driven by expanding healthcare infrastructure, increasing awareness of sleep health, and greater adoption of wearable and connected medical technologies. Growing urbanization and changing lifestyles are contributing to increased attention toward sleep quality and circadian health, creating opportunities for actigraphy-based monitoring solutions. Improvements in access to specialized healthcare and diagnostic services are further supporting demand, while the expansion of digital health ecosystems is making wearable monitoring technologies more accessible. Increasing clinical and research activity related to sleep disorders is also expected to reinforce the region's adoption of actigraphy devices.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Research-Driven DiagnosticsGermany emphasizes actigraphy devices that deliver reliable long-term activity and sleep monitoring for clinical and academic applications. Organizations in Germany focus on validated measurement performance and integration with established diagnostic workflows.
France 🇫🇷
Sleep Research ApplicationsFrance focuses on actigraphy devices that support sleep medicine, behavioral research, and long-term patient observation. Clinical users in France prioritize dependable monitoring solutions that complement laboratory assessments and outpatient care programs.
Italy 🇮🇹
Ambulatory Monitoring SupportItaly utilizes actigraphy devices to strengthen ambulatory sleep assessment and routine patient follow-up outside hospital environments. Healthcare professionals in Italy increasingly adopt user-friendly wearable solutions that improve longitudinal monitoring and clinical workflow efficiency.
Japan 🇯🇵
Compact Wearable AssessmentJapan prioritizes compact actigraphy devices that provide continuous monitoring with minimal disruption to daily routines. Healthcare institutions in Japan increasingly value accurate data collection and user comfort for sleep and circadian rhythm evaluation.
South Korea 🇰🇷
Digital Health IntegrationSouth Korea advances the use of actigraphy devices through connected healthcare ecosystems and wearable technology adoption. Providers in South Korea emphasize seamless data sharing, remote monitoring capabilities, and efficient patient engagement across clinical settings.
United States 🇺🇸
Clinical Sleep MonitoringThe U.S. actigraphy device market prioritizes wearable monitoring solutions for sleep assessment, clinical research, and remote patient management. Healthcare providers in the U.S. increasingly integrate actigraphy data into digital health platforms to support evidence-based care decisions.
Segment Leadership and Growth Trends
Actigraphy Device Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Sleep Disorders (Largest Segment) vs Chronic Disease Management (Fastest-Growing Segment)
The sleep disorders segment represented the largest share of the actigraphy device market in 2026, driven by the growing use of objective sleep and activity measurements to support the assessment of sleep patterns and circadian rhythms. Actigraphy provides a practical means of collecting continuous behavioral data outside conventional clinical environments, making it valuable for evaluating sleep quality and identifying irregular sleep-wake patterns. Increasing awareness of sleep health and the need for longitudinal monitoring are reinforcing adoption among healthcare professionals and specialized sleep-care settings.
Chronic disease management is the fastest-growing application segment as actigraphy expands beyond dedicated sleep assessment into broader monitoring of activity patterns, rest cycles, and patient behavior. Chronic conditions often require ongoing observation of lifestyle and functional changes, creating demand for wearable approaches that can provide continuous information without imposing substantial disruption on daily routines. The growing emphasis on remote monitoring, personalized care, and preventive management is broadening the clinical relevance of actigraphy devices.
End Use Segment Analysis: Healthcare Providers (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)
Healthcare providers held the largest share of the actigraphy device market in 2026, reflecting the central role of hospitals, clinics, and specialist practices in diagnosing sleep-related conditions and interpreting patient activity data. These settings benefit from professional expertise needed to integrate actigraphy results with clinical assessments and treatment decisions. Wider adoption of objective monitoring tools in routine care is strengthening the position of healthcare providers as an important end-use group.
Homecare settings are experiencing the fastest growth as healthcare delivery increasingly shifts toward patient monitoring outside conventional clinical facilities. Actigraphy devices can capture sleep and activity information during normal daily routines, supporting convenient observation while reducing the need for repeated in-person assessments. The expansion of remote care models, growing patient preference for home-based monitoring, and increased focus on continuous health management are creating stronger demand for actigraphy solutions in residential environments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Sleep Disorders, Physical Activity Monitoring, Chronic Disease Management | Sleep Disorders | Chronic Disease Management |
| End Use | Healthcare Providers, Research Institutions, Homecare Settings, Fitness and Sports Centers | Healthcare Providers | Homecare Settings |
Competitive Landscape and Market Positioning
Major players in the actigraphy device market:
1. Koninklijke Philips N.V. (Netherlands)
2. ActiGraph LLC (United States)
3. Empatica Inc. (United States)
4. CamNtech Ltd. (United Kingdom)
5. Fibion Inc. (Finland)
6. ActivInsights Ltd. (United Kingdom)
7. neurocare group AG (Germany)
8. Garmin Ltd. (Switzerland)
9. Fitbit LLC (United States)
10. Withings S.A. (France)
The competitive dynamics of the actigraphy device market are increasingly shaped by advancements in digital health monitoring and wearable integration. Market participants are prioritizing the development of compact, data-driven solutions capable of delivering improved sleep and activity tracking accuracy. Rising demand for remote patient monitoring has also accelerated investments in sensor innovation, mobile connectivity, and analytics platforms. Alongside these developments, continuous R&D efforts are supporting the launch of user-friendly devices tailored for both clinical and consumer wellness applications, strengthening innovation intensity across the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Koninklijke Philips N.V. (Netherlands) | |||||||
| ActiGraph LLC (United States) | |||||||
| Empatica Inc. (United States) | |||||||
| CamNtech Ltd. (United Kingdom) | |||||||
| Fibion Inc. (Finland) | |||||||
| ActivInsights Ltd. (United Kingdom) | |||||||
| neurocare group AG (Germany) | |||||||
| Garmin Ltd. (Switzerland) | |||||||
| Fitbit LLC (United States) | |||||||
| Withings S.A. (France). |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Actigraphy Device Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Device Form Factor | Wrist-Worn Devices, Ankle-Worn Devices, Chest-Worn Devices, Bedside/Non-Wearable Devices |
| Connectivity | Bluetooth-Enabled, Wi-Fi-Enabled, Cellular-Enabled, USB/Offline Data Transfer |
| Procurement Model | Direct Purchase, Institutional Procurement, Subscription-Based Models, Device Rental/Leasing |
Actigraphy Device Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Pathway Assessment |
|
| Digital Health Integration Landscape |
|
| Home-Based Patient Monitoring Opportunities |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the actigraphy device market?
What are the growth projections for the actigraphy device industry?
How is demand for continuous sleep monitoring accelerating adoption of actigraphy devices?
Why are non-invasive sleep assessment technologies gaining importance in aging care pathways?
Why are healthcare providers the largest end users in the actigraphy device market?
Why is chronic disease management the fastest-growing application in the actigraphy device market?
Why does North America lead the actigraphy device market?
What is driving growth in Asia Pacific actigraphy device market?
Which companies are driving growth in the actigraphy device landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization